Scandinavian Chemotech: New Structure, Record Sales & Key Clinical Data Ahead - Redeye

CEO Mohan Frick and Chairman Robin Sukhia discuss the company’s proposed restructuring, the Nasdaq verdict, and what the split into Animal Care and Human Care means strategically. They also address the record Q1 sales figures, the IQWave approval in India, a directed share issue to reduce debt, and upcoming clinical data on TSE in Equine Sarcoid Management at the European College of Veterinary Surgeons in Liverpool this July.

Länk till analysen i sin helhet: https://www.redeye.se/research/1159219/scandinavian-chemotech-new-structure-record-sales-key-clinical-data-ahead?utm_source=finwire&utm_medium=RSS